Dipna Pharmachem (BOM:543594) Long-Term Debt: ₹101 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543594 Dipna Pharmachem Ltd BOM:543594
66 GF Score
Price ₹5.80
GF Value ₹8.92
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Dipna Pharmachem Long-Term Debt?

Dipna Pharmachem BOM:543594 +4.93% 66 Long-Term Debt is ₹101 Mil as of Mar. 2026. GuruFocus rates BOM:543594 with a GF Score™ of 66/100 and a GF Value™ of ₹8.92 (Possible Value Trap). The stock has 9 warning signs investors should review.

Dipna Pharmachem's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹101 Mil.

Dipna Pharmachem's quarterly Long-Term Debt increased from Mar. 2025 (₹89 Mil) to Sep. 2025 (₹105 Mil) but then declined from Sep. 2025 (₹105 Mil) to Mar. 2026 (₹101 Mil).

Dipna Pharmachem's annual Long-Term Debt declined from Mar. 2024 (₹125 Mil) to Mar. 2025 (₹89 Mil) but then increased from Mar. 2025 (₹89 Mil) to Mar. 2026 (₹101 Mil).

Dipna Pharmachem  (BOM:543594) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dipna Pharmachem Long-Term Debt Related Terms

Dipna Pharmachem Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Dipna Pharmachem's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dipna Pharmachem Long-Term Debt Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial 57.98 109.69 125.47 88.90 101.00

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.47 149.36 88.90 105.30 101.00
BOM:543594
66GF Score
Dipna Pharmachem Ltd BOM:543594
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹101 Mil mean?
Dipna Pharmachem (BOM:543594) has a Long-Term Debt of ₹101 Mil as of Mar. 2026.
Is Dipna Pharmachem's Long-Term Debt too high?
Dipna Pharmachem's current Long-Term Debt is ₹101 Mil. Overall, Dipna Pharmachem has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's Long-Term Debt compare to competitors?
Dipna Pharmachem's Long-Term Debt of ₹101 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Dipna Pharmachem's current Long-Term Debt is ₹101 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹8.92, compared to a current price of ₹5.80 — trading 35% below its estimated fair value. The current Long-Term Debt is ₹101 Mil. Dipna Pharmachem's overall GF Score™ is 66/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current Long-Term Debt is ₹101 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?

Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued. The current stock price of ₹5.80 is trading 35% below its estimated GF Value™ of ₹8.92. GuruFocus considers Dipna Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:543594:

  • Long-Term Debt: ₹101 Mil
  • GF Value™: ₹8.92 vs. price of ₹5.80 (35% below fair value)
  • GF Score™: 66/100 with 9 warning signs

No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dipna Pharmachem Business Description

Address A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
66GF Score

Get the complete analysis for BOM:543594

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.80
Price
₹8.92
GF Value